Working... Menu
Trial record 13 of 49 for:    "Central Nervous System Lymphoma" | "Vitamin B9"

Temozolomide in Treatment of Patients With Primary Central Nervous System Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02934204
Recruitment Status : Unknown
Verified May 2016 by Guangdong General Hospital.
Recruitment status was:  Recruiting
First Posted : October 14, 2016
Last Update Posted : October 14, 2016
Information provided by (Responsible Party):
Guangdong General Hospital

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : February 2019
  Estimated Study Completion Date : February 2019